Surgeons in the Heart Center at Boston Children's Hospital have partnered with Edwards Lifesciences to launch a clinical study of a new prosthetic heart valve for patients born with a congenital heart defect. Called the COMMENCE - Pulmonary Valve Trial, the study will include up to 10 pediatric heart centers from around the U.S.; Boston Children's is the trial's lead site.
↧